FY2015 Regulatory Science Research Report: Long-Acting Injectable Formulations. U.S. Food and Drug Administration. https://www.fda.gov/industry/generic-drug-user-fee-amendments/fy2015-regulatory-science-research-report-long-acting-injectable-formulations. Date Accessed August 5, 2026.
PLGA-Based Biodegradable Microspheres in Drug Delivery: Recent Advances in Research and Application. Drug Delivery (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8248937/. Date Accessed August 5, 2026.
PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery. International Journal of Molecular Sciences (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC8396256/. Date Accessed August 5, 2026.
LUPRON DEPOT (Leuprolide Acetate for Depot Suspension): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd. Date Accessed August 5, 2026.
RISPERDAL CONSTA (Risperidone Long-Acting Injection): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb34ee82-d2c2-43b8-ba21-2825c0954691. Date Accessed August 5, 2026.